Unilever announced on Monday it has agreed to buy GlaxoSmithKline Consumer Nutrition business in India, including hot malted drink Horlicks.
The deal is expected to cost Unilever €3.3bn ($3.8bn) and will be paid through shares of its Indian unit Hindustan Unilever as well as cash of no more than €639m.